Europe — EMA
Ommunal Adulti
GNH USA supplies Ommunal Adulti (Lyophilized Bacterial Lysates), a biologic immunostimulant for recurrent respiratory infections and post‑operative immune
Request sourcing
What is Lyophilized Bacterial Lysates Of: Haemophilus Influenzae Streptococcus (Diplococcus) Pneumoniae Kleb?
Lyophilized Bacterial Lysates Of: Haemophilus Influenzae Streptococcus (Diplococcus) Pneumoniae Kleb, the active ingredient in Ommunal Adulti, is a biologic presented as a lyophilized powder for parenteral use. It is intended to modulate immune responses in individuals requiring immunostimulatory support.
GNH USA supplies Ommunal Adulti as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Lyophilized Bacterial Lysates Of: Haemophilus Influenzae Streptococcus (Diplococcus) Pneumoniae Kleb used for?
Ommunal Adulti is employed as an immunostimulant in clinical contexts where enhancement of host defence mechanisms is desired. - Recurrent respiratory infections: May help reduce the frequency of infections in susceptible adults. - Post‑operative immune support: Intended to aid recovery of immune function after major surgery. - Chronic bronchitis exacerbations: Used to support immune defence during flare‑ups. - Seasonal viral prophylaxis: Administered to bolster immunity during periods of high viral circulation.
What are the side effects of Lyophilized Bacterial Lysates Of: Haemophilus Influenzae Streptococcus (Diplococcus) Pneumoniae Kleb?
Adverse reactions reported with bacterial lysate immunostimulants are generally mild and related to the route of administration.
Common Side Effects: - Injection site pain: Discomfort at the site of subcutaneous or intramuscular injection. - Low‑grade fever: Transient temperature rise within 24 hours. - Mild headache: Occasional tension‑type headache. - Fatigue: Temporary feeling of tiredness. - Local erythema: Redness around the injection area.
Serious or Rare Side Effects: - Anaphylaxis: Severe allergic reaction requiring immediate medical attention. - Serum sickness‑like reaction: Joint pain, rash and fever occurring days after dosing. - Severe local necrosis: Tissue damage at the injection site. - Autoimmune flare: Exacerbation of pre‑existing autoimmune disease. - Hypotension: Unexplained drop in blood pressure post‑administration.
What precautions apply to Lyophilized Bacterial Lysates Of: Haemophilus Influenzae Streptococcus (Diplococcus) Pneumoniae Kleb?
Before initiating therapy with Ommunal Adulti, clinicians should evaluate patient history and follow standard safety measures. - Allergy assessment: Confirm no known hypersensitivity to bacterial lysates or any component of the formulation. - Immunocompromised status: Use with caution in patients with severe immunodeficiency. - Autoimmune disease: Monitor closely if the patient has active autoimmune conditions. - Concomitant vaccines: Schedule administration to avoid overlapping immune activation. - Pregnancy and lactation: Weigh potential benefits against unknown risks; use only if clearly indicated. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Lyophilized Bacterial Lysates Of: Haemophilus Influenzae Streptococcus (Diplococcus) Pneumoniae Kleb interact with?
Ommunal Adulti may interact with other agents that influence immune function. Clinical judgement should guide co‑administration.
Major Interactions (Avoid): - Live attenuated vaccines: Concurrent use may reduce vaccine efficacy or increase adverse events. - High‑dose corticosteroids: May blunt the immunostimulatory effect of the lysate.
Moderate Interactions (Monitor Closely): - Immunomodulatory biologics (e.g., anti‑TNF agents): May alter response to bacterial lysates. - Antipyretics (acetaminophen, ibuprofen): May mask low‑grade fever, a common post‑dose sign. - Antihistamines: Could diminish mild injection‑site reactions, affecting safety monitoring. - Cytokine‑targeting therapies: Potential for synergistic immune activation. - Hematopoietic growth factors: Overlap in immune‑stimulating pathways warrants observation.